Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripheral Biomarkers for First-Episode Psychosis—Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia
Nuno Trovão, Joana Prata, Orlando von Doellinger, et al.
Psychiatry Investigation (2019) Vol. 16, Iss. 3, pp. 177-184
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The Role of Cytokines in the Pathogenesis of Schizophrenia
Bartosz Dawidowski, Adrianna Górniak, Piotr Podwalski, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3849-3849
Open Access | Times Cited: 73
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110626-110626
Closed Access | Times Cited: 60
On the proportion of patients who experience a prodrome prior to psychosis onset: A systematic review and meta-analysis
David Benrimoh, Viktor Dlugunovych, Abigail C. Wright, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 5, pp. 1361-1381
Open Access | Times Cited: 9
Increased C‐reactive protein concentration and suicidal behavior in people with psychiatric disorders: A systematic review and meta‐analysis
Alessandro Miola, Veronica Dal Porto, Tal Tadmor, et al.
Acta Psychiatrica Scandinavica (2021) Vol. 144, Iss. 6, pp. 537-552
Open Access | Times Cited: 50
Peripheral immunity and risk of incident brain disorders: a prospective cohort study of 161,968 participants
Xiaoling Zhong, Yi‐Xuan Qiang, Ling Wang, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 20
The complement system in neurodegenerative and inflammatory diseases of the central nervous system
Luciana Negro-Demontel, Adam F. Maleki, Daniel S. Reich, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 8
Immune network dysregulation associated with child neurodevelopmental delay: modulatory role of prenatal alcohol exposure
Tamara S. Bodnar, Charlis Raineki, Wladimir Wertelecki, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 46
The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
Melisa Kose, Carmine M. Pariante, Paola Dazzan, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 40
Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia
Elżbieta Kozłowska, Ewa Brzezińska‐Błaszczyk, Justyna Agier, et al.
Journal of Psychiatric Research (2021) Vol. 138, pp. 380-387
Open Access | Times Cited: 39
Everolimus inhibits PI3K/Akt/mTOR and NF-kB/IL-6 signaling and protects seizure-induced brain injury in rats
Xiangyi Huang, Qing-peng Hu, Hongyun Shi, et al.
Journal of Chemical Neuroanatomy (2021) Vol. 114, pp. 101960-101960
Closed Access | Times Cited: 33
Natural compounds for oxidative stress and neuroprotection in schizophrenia: composition, mechanisms, and therapeutic potential
Anam N. Khan, Rahul D. Jawarkar, Magdi E. A. Zaki, et al.
Nutritional Neuroscience (2024) Vol. 27, Iss. 11, pp. 1306-1320
Closed Access | Times Cited: 6
The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders
Annalisa Palmisano, Siddhartha Pandit, Carmelo Smeralda, et al.
Life (2024) Vol. 14, Iss. 5, pp. 578-578
Open Access | Times Cited: 5
Elevated Osteopontin and Interferon Gamma Serum Levels and Increased Neutrophil-to-Lymphocyte Ratio Are Associated With the Severity of Symptoms in Schizophrenia
Márton Kovács, Tamás Tényi, Réka Kugyelka, et al.
Frontiers in Psychiatry (2020) Vol. 10
Open Access | Times Cited: 31
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup
Paolo Enrico, Giuseppe Delvecchio, Nunzio Turtulici, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 3, pp. 1190-1200
Closed Access | Times Cited: 10
Changes in schizophrenia symptoms, tryptophan metabolism, neuroinflammation and the GABA-glutamate loop: A pilot study
E. Van der Walt, C. Brink, Esmé Jansen van Vuren
South African Journal of Psychiatry (2025) Vol. 31
Open Access
Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controls
Anna Michalczyk, Ernest Tyburski, Piotr Podwalski, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 116, pp. 110510-110510
Closed Access | Times Cited: 16
Correlation of BDNF, VEGF, TNF‐α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients
Phatcharee Chukaew, Nutthaya Bunmak, Natchaphon Auampradit, et al.
Neuropsychopharmacology Reports (2022) Vol. 42, Iss. 3, pp. 281-287
Open Access | Times Cited: 16
MicroRNAs and pro-inflammatory cytokines as candidate biomarkers for recent-onset psychosis
Ali Reza Shafiee‐Kandjani, Negin Nezhadettehad, Sara Farhang, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Peripheral Blood-Based Gene Expression Studies in Schizophrenia: A Systematic Review
Vipul V. Wagh, Parin Vyas, Suchita Agrawal, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 19
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first‐episode psychosis
Carlo Maj, Sarah Tosato, Roberta Zanardini, et al.
Early Intervention in Psychiatry (2019) Vol. 14, Iss. 4, pp. 507-511
Closed Access | Times Cited: 21
Potential role between inflammatory cytokines and Tie-2 receptor levels and clinical symptoms in patients with first-episode schizophrenia
Fanfan Yan, Xiaojing Meng, Xialong Cheng, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Multivariate analyses of immune markers reveal increases in plasma EN-RAGE in first-episode psychosis patients
Laura Korhonen, Elisabeth Paul, Karin Wåhlén, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
The association between serum levels of TNF-α and IL-6 in schizophrenic patients and their metabolic status – A case control study
Jaśmina Arabska, Dominik Strzelecki, Elżbieta Kozłowska, et al.
Journal of Neuroimmunology (2020) Vol. 347, pp. 577344-577344
Closed Access | Times Cited: 13
Immune-inflammatory markers in remission after a first-episode psychosis in young patients
S. A. Zozulya, D. V. Tikhonov, В. Г. Каледа, et al.
S S Korsakov Journal of Neurology and Psychiatry (2021) Vol. 121, Iss. 6, pp. 59-59
Closed Access | Times Cited: 12
Serum Inflammatory Markers and Their Associations with the Integrity of the Cingulum Bundle in Schizophrenia, from Prodromal Stages to Chronic Psychosis
Anna Michalczyk, Ernest Tyburski, Piotr Podwalski, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6352-6352
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top